Piper Sandler Upgrades Replimune Group (REPL) to Overweight
Piper Sandler analyst Allison Bratzel upgraded Replimune Group (NASDAQ: REPL) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
